腹膜透析联合血液透析治疗慢性肾功能衰竭的应用优势分析及研究

Analysis and Study on the Application of Hemodialysis Combined with Hemodialysis for Chronic Renal Failure

目的探讨腹膜透析联合血液透析治疗慢性肾功能衰竭的应用优势。方法将2016年1月至2016年11月76例慢性肾功能衰竭患者作为研究对象根据方法分组,各有38例。对照组采用腹膜透析治疗,联合组采用腹膜透析联合血液透析治疗。比较两组KT/V达标率;并发症发生率;干预前后患者尿素氮、肌酐、白蛋白、血红蛋白;钙、磷、甲状旁腺激素。结果联合组KT/V达标率高于对照组,P<0.05;两组患者未发生严重并发症;干预前两组尿素氮、肌酐、白蛋白、血红蛋白、钙、磷、甲状旁腺激素相近,P>0.05;干预后联合组尿素氮、肌酐、白蛋白、血红蛋白、钙、磷、甲状旁腺激素优于对照组,P<0.05。结论腹膜透析联合血液透析治疗慢性肾功能衰竭的效果确切,可有效改善肾功能、血液学指标,提高尿素清除率,无严重并发症,安全有效,值得推广应用。

Objective To explore the advantage of hemodialysis combined with hemodialysis for chronic renal failure. Methods From January 2016 to November 2016, 76 patients with chronic renal failure were grouped according to the method, 38 cases were respectively. The control group was treated with peritoneal dialysis, and the combined group was treated with peritoneal dialysis combined with hemodialysis. Compare two sets of KT/V rates; Incidence of complications; The patients before and after the intervention urea nitrogen, creatinine, albumin, hemoglobin; Calcium, phosphorus, parathyroid hormone. Results The combined group KT/V was higher than the control group, P〈 0.05. No serious complications occurred in the two groups; the two groups of urea nitrogen, creatinine, albumin, hemoglobin, calcium, phosphorus, and parathyroid hormone were similar in the first two groups, P〉0.05; after intervention, the combined group urea nitrogen, creatinine, albumin, hemoglobin, calcium, phosphorus, and parathyroid hormone were superior to the control group, P 〈0.05. Conclusion The effect of peritoneal dialysis combined hemodialysis in patients with chronic renal failure, exactly can effectively improve the kidney function, hematology indexes, improve urea clearance, no serious complications, safe, effective and worth popularization and application.